Chordoma is a malignant tumor that usually involves the axial skeleton. They originate from remnants of the primitive notochord, with incidence of approximately 35% in clivus and 50% in sacrococcygeal region. Chordomas account for 1% of all primary brain tumors.
Treatment is often difficult because the tumor is refractory to traditional cytotoxic agents and conventional radiotherapy, making block resection the main choice.
We described previously an uncommon case of intratumoral bleeding in an intradural posterior fossa chordoma mimicking a spontaneous intraparenchymatous hemorrhage.
We present a 33-year-old woman previously submitted to five brain surgeries to treat intradural chordoma of the posterior fossa since December 2012.
Currently, she presented almost with right and left hemiplegia (grade 2 bilaterally) and left oculomotor, abducent and facial nerve paresis. Additionally, there was dysphagia, dysarthria, and appendicular ataxia. She also complained of low back pain, coccydynia and stool and urinary retention, needing daily use of stool softeners and bladder catheterization thrice to four times/day.
We performed neuroaxis magnetic resonance MR, which disclosed stability of posterior fossa tumor that was previously irradiated (
Chordomas are lesions with difficult management due to recurrence and progressive clinical deterioration of patient with small chances of cure. When there is impossibility of resection or multiple recurrences management changes towards improvement of neurological symptoms and improvement in quality of life.
Figure 1 MR imaging. In A, sagittal and axial T2 and T1 gadolinium enhanced images revealing intradural chordoma metastasis at the level of C3. In B, the additional evaluation of brain and spine at that moment. There was residual lesion in posterior fossa, a lesion in thoracic spinal cord and also in lombossacral roots at the level of L4-L5-S1.
In addition to the neurological symptoms caused by the disease or the sequelae of treatments, psychological symptoms (anxiety, depression, etc.), and spiritual needs are usually present from diagnosis.
Since we have a disease with no prospects for a cure and the presence of symptoms that are difficult to control, the introduction of palliative care in conjunction with antineoplastic treatment is recommended and highlighted by publications of the American Society of Clinical Oncology (ASCO),
The objective of palliative care is to provide better control of physical, psychosocial, and spiritual symptoms, extending this view of care to family members, for whom mourning assistance is also appropriate, especially in young patients as in the case reported.
The inability to control the sphincters is among the uncomfortable symptoms that are said to be worse than death.
This retrospective study which was submitted to Institutional Ethics and Human Research Committee approved under the CAEE (certificate do presentation of ethical appreciation) number 52340621.8.0000.0070 and under opinion No. 5.047.138.
Pelvic physical therapy procedure:
The physical evaluation was performed by the pelvic floor muscle assessment (PERFECT),
In the evaluation, the patient presented: a) PERFECT with grade P0, E0, R0, F0, CS, TS the cocontraction was minimal; b) Perineal muscle tone was weak; c) Sensitivity test showed hyposensitivity in the region of the entire perineum (large and small vulvar lips), tingling paresthesia in the body of the perineum and pubic region and pain in the region close to the sacral region due to tumor damage; d) positive motor test without voluntary movement of the lower limbs.
After the initial evaluation, urinary retention and severe constipation were detected (according to the Rome IV criteria).
The patient was submitted to a rehabilitation program of the perineal region, every day, once a day and lasting approximately 45 minutes each session in her bed, totaling 6 face-to-face sessions plus guidance with the family member to be carried out at home. The sessions consisted of using electrotherapy (CARCI, São Paulo, Brazil) in FES mode (functional electrical stimulation) in the transverse region of the abdomen plus the perineal body region for learning perineal relaxation and were divided into two phases each of eight minutes with a second ON, one second OFF, and one second ON and two seconds OFF together guiding the importance of relaxation for urine output.
Incomplete neural injuries may be common in oncologic pictures like the present case. In such cases, remaining neural stimuli become responsible for the innervation of a greater number of muscle fibers and produce less effective contractions, causing loss of urethral support.
Electrical stimulation is believed to be able to increase intraurethral pressure through direct stimulation of the efferent nerves to the periurethral musculature, and by improving local blood flow.
The proposal made for this patient was divided into two stages: the first with rapid contractions in search of strengthening the pelvic floor and the other with longer relaxation time, prioritizing adequate relaxation for spontaneous urination and thus removing the use of the urinary catheter for relief.
In addition to the FES electrotherapy, electrotherapy was performed in TENS mode (transcutaneous electrical nerve stimulation) in the parasacral region to improve constipation. Before performing bladder catheterization, patient was encouraged to relax the region and try to urinate spontaneously. To do so, patient was kept seated and abdominal massages for fecal motility and bladder stimuli were also done.
The choice to use the parasacral ES was due to lower limbs motor deficits. Although many mechanisms are still uncertain regarding the use of electrostimulation (EE) or electroacupuncture, several studies suggest that it results in an increase in gastrointestinal motility, probably via reflex with activation of the supraspinal pathways that contribute to the effectiveness of intestinal function.
In addition to the FES electrotherapy, electrotherapy was performed in TENS mode (transcutaneous electrical nerve stimulation) in the parasacral region to improve constipation.
The data with the functional improvement are shown in
After the patient performed six pelvic physiotherapy sessions in order to bring quality of life to the urinary and fecal systems, she began to obtain positive results with an improvement in the urinary condition. After the patient left the hospital, she remained in remote contact with the physiotherapist for behavioral adjustments and daily exercises in the pelvic region, thus obtaining 100% improvement in her urinary condition. The fecal condition remained diagnosed with constipation.
The patient reported a great and expressive improvement in her quality of life as she returned to independence to perform her spontaneous bladder voiding.
| Session I | Session II | Session III | Session IV | Session V | Session VI |
|---|---|---|---|---|---|
| FES (8', 01 ON, 1 OFF) FES (8', 01 ON, 02 OFF) | FES (8', 01 ON, 1 OFF) FES (8', 01 ON, 02 OFF) | FES (8', 01 ON, 1 OFF) FES (8', 01 ON, 02 OFF) | FES (8', 01 ON, 1 OFF) FES (8', 01 ON, 02 OFF) | FES (8', 01 ON, 1 OFF) FES (8', 01 ON, 02 OFF) | FES (8', 01 ON, 1 OFF) FES (8', 01 ON, 02 OFF) |
| PARASACRAL TENS L 200US, 10 HZ, 20 ‘ | PARASACRAL TENS L 200US, 10 HZ, 20 ‘ | PARASACRAL TENS L 200US, 10 HZ, 20 ‘ | PARASACRAL TENS L 200US, 10 HZ, 20 ‘ | PARASACRAL TENS L 200US, 10 HZ, 20 ‘ | PARASACRAL TENS L 200US, 10 HZ, 20 ‘ |
| Got in a little amount of spontaneous urination | Functional improvement but with 500 ml bladder residue | No spontaneous urination | 380 ml present urination + evacuation | 380 ml urination + urination present during the session | Spontaneous urination of at least 300 ml at a time |
Chordomas are rare, locally aggressive neoplasms of notochordal origin, accounting for 1% to 4% of all bone malignancies and 0.5% of all primary intracranial central nervous system.
The impact of rehabilitation and quality of life measures in such patients is almost unknown. Some papers have already pointed the challenges and impact of chordoma symptoms and treatment in quality of life, however up to date there is no report of specific rehabilitation program used in the course of disease.[23,24]
Our case illustrates a late (7 years) follow-up presentation of an initial posterior fossa intradural chordoma. Probably due to surgical and adjuvant therapies, patient could experience a larger time of life and thus presented with bone and intradural tumoral spread, leading to motor and visceral symptoms. Even with limited survival time due to malignant nature of disease, it is possible to address specific symptoms such as pelvic ones and improve functions to reduce burden and improve quality of life.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Journal: Brazilian Journal of Oncology
DOI: 10.1055/s-00059887
e-issn: 2526-8732
Publisher: Thieme Revinter Publicações Ltda.
Publisher address: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
No citations found for this article.
1. Vellutini, EAS and Oliveira, MF. Intradural chordoma presenting with intratumoral bleeding. J Clin Neurosci [online]. 2016, vol. 25, p. 139-142.
2. Zhang, J and Gao, CP and Liu, XJ and Xu, WJ. Intradural cervical chordoma with diffuse spinal leptomeningeal spread: case report and review of the literature. Eur Spine J [online]. 2018, vol. 27, p. 440-445.
3. Vellutini, EAS and Brock, RS and Martins, HO and Taricco, MA and Oliveira, MF. Diffuse spinal spreading following previous intracranial intradural chordoma resection: a rare case report. J Clin Neurosci [online]. 2019, vol. 64, p. 44-46.
4. Das, P and Soni, P and Jones, J and Habboub, G and Barnholtz-Sloan, JS and Recinos, PF. Descriptive epidemiology of chordomas in the United States. J Neurooncol [online]. 2020, vol. 148, p. 173-178.
5. Frezza, AM and Botta, L and Trama, A and Dei Tos, A and Stacchiotti, S. Chordoma: update on disease, epidemiology, biology and medical therapies. Curr Opin Oncol [online]. 2019, vol. 31, p. 114-120.
6. Whelan, JS and Davis, LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol [online]. 2018, vol. 36, p. 188-193.
7. Song, PH and Beyhaghi, H and Sommer, J and Bennett, AV. Symptom burden and life challenges reported by adult chordoma patients and their caregivers. Qual Life Res [online]. 2017, vol. 26, p. 2237-2244.
8. Diaz, RJ and Maggacis, N and Zhang, S and Cusimano, MD. Determinants of quality of life in patients with skull base chordoma. J Neurosurg [online]. 2014, vol. 120, p. 528-537.
9. Schwab, JH and Janssen, SJ and Pereira, NRP and Chen, YLE and Wain, JC and DeLaney, TF. Quality of life after resection of a chordoma of the mobile spine. Bone Joint J [online]. 2017, vol. 99, p. 979-986.
10. Ferrell, BR and Temel, JS and Temin, S and Alesi, ER and Balboni, TA and Basch, EM. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol [online]. 2017, vol. 35, p. 96-112.
11. Ferrell, BR and Temel, JS and Temin, S and Smith, TJ. Integration of palliative care into standard oncology care: ASCO clinical practice guideline update summary. J Oncol Pract [online]. 2017, vol. 13, p. 119-121.
12. Jordan, K and Aapro, M and Kaasa, S and Ripamonti, CI and Scotté, F and Strasser, F. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol [online]. 2018, vol. 29, p. 36-43.
13. Dans, M and Smith, T and Back, A and Baker, JN and Bauman, JR and Beck, AC. NCCN guidelines insights: palliative care, version 2.2017. J Natl Compr Canc Netw [online]. 2017, vol. 15, p. 989-997.
14. Rubin, EB and Buehler, AE and Cooney, E and Gabler, NB and Mante, AA and Halpern, SD. Intuitive vs deliberative approaches to making decisions about life support: a randomized clinical trial. JAMA Netw Open [online]. 2019, vol. 2, p. e187851.
15. Laycock, JO and Jerwood, D. Pelvic floor muscle assessment: the PERFECT scheme. Physiotherapy [online]. 2001, vol. 87, p. 631-642.
16. Van Wulfften Palthe, ODR and Janssen, SJ and Wunder, JS and Ferguson, PC and Wei, G and Rose, PS. What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey. Spine J [online]. 2017, vol. 17, p. 636-644.
17. Simren, M and Palsson, OS and Whitehead, WE. Update on Rome IV criteria for colorectal disorders: implications for clinical practice. Curr Gastroenterol Rep [online]. 2017, vol. 19, p. 15.
18. Rodrigues, JA and Moreira, AC and Elias, LLK and Castro, M. Neuroendocrinologia básica e aplicada. Guanabara Koogan;, 2006.
19. Cestari, EC and Souza, THC and Silva, SA. Eletroestimulação no tratamento da incontinência urinária esforço feminina. Rev Ciênc Estud Acad Med [online]. 2016, vol. 1, p. 93-101.
20. Grosse, D and Sengler, J. Reeducação perineal: concepção, realização e transcrição em prática liberal e hospitalar. Manole;, 2002.
21. Browning, KN and Travagli, RA. Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol [online]. 2014, vol. 4, p. 1339-1368.
22. Luo, S and Xu, H and Zuo, Y and Liu, X and All, AH. A review of functional electrical stimulation treatment in spinal cord injury. Neuromol Med [online]. 2020, vol. 22, p. 447-463.
Dados de acesso insuficientes para visualização no mapa.